Pancreatic bleeding診断
Bleeding through the pancreatic duct can be difficult to locate, especially when it stops and starts. Learn which symptoms need emergency care and how specialists investigate the source.
医学的レビュー: トーマス・クライン, 、MD
要点
- 定義: Hemosuccus pancreaticus is gastrointestinal bleeding that enters the pancreatic duct and flows into the small intestine.
- Emergency signs: Vomiting blood, black tarry stool, fainting, or severe weakness can signal a dangerous bleed; seek emergency care immediately.
- Intermittent bleeding: A first endoscopy can miss the source if bleeding has stopped or the duct opening is not clearly seen.
- Common setting: Pancreatitis and a nearby arterial pseudoaneurysm are recognized causes, but not everyone has a known pancreatic condition.
- 画像診断: CT angiography can identify an abnormal artery or active bleeding; a negative scan does not always exclude an intermittent bleed.
- Specialist treatment: Catheter angiography can both locate an arterial source and allow embolization to stop it.
- Blood tests: Hemoglobin helps assess anemia, but an early result can be normal and cannot identify the bleeding site.
- Stool tests: A positive or negative stool blood test cannot establish whether blood came from the pancreatic duct.
What happens in hemosuccus pancreaticus?
Hemosuccus pancreaticus occurs when blood enters the pancreatic duct and passes through its opening into the duodenum, the first part of the small intestine. It is a rare cause of gastrointestinal bleeding.

The pancreas sits behind the stomach and makes digestive enzymes. Its main duct normally carries these enzymes to the duodenum through an opening called the major papilla.
A damaged artery near the pancreas can connect with the duct, sometimes through a pancreatic fluid collection. Blood then follows the duct into the digestive tract rather than appearing at an obvious ulcer on the stomach lining.
その他の 便中の血液 are much more common. Symptoms alone cannot establish that the pancreas is the source.
What are the symptoms of hemosuccus pancreaticus?
Hemosuccus pancreaticus symptoms can include black tarry stools, upper abdominal pain, weakness, dizziness, or vomiting blood. Some people have recurrent episodes separated by symptom-free intervals.

Black, sticky stool with a strong odor is called メレナ and can occur when blood is digested as it travels through the gut. Iron tablets and some medicines can also darken stool, but a new tarry stool needs urgent assessment.
Abdominal pain may accompany bleeding, although not every patient has pain. A clot within the pancreatic duct may obstruct drainage and contribute to discomfort, but pain alone does not establish the diagnosis.
Heavy gastrointestinal bleeding can occasionally cause bright red or maroon stool rather than black stool. For comparison, other digestive symptoms have different possible causes and do not identify a pancreatic source.
Which symptoms require emergency care?
Vomiting blood or material resembling coffee grounds, passing black tarry stool, fainting, or experiencing severe weakness with suspected bleeding requires immediate emergency evaluation. Call emergency services if the person is collapsing, confused, short of breath, or unable to travel safely.

Do not drive yourself if you feel faint, and do not wait for a stool test or an AI interpretation. A bleed that seems to stop can restart and become life-threatening.
Tell the emergency team about previous pancreatitis, pancreatic fluid collections, procedures, and any blood-thinning medicines. Bring a medication list if it is immediately available, but do not delay getting help to find it.
Fresh rectal bleeding also needs prompt medical assessment; a large amount, dizziness, fainting, or severe abdominal pain makes it an emergency. Our guide to 便中の血液 explains why a positive screening result still needs a clinician-led investigation.
What causes bleeding from the pancreatic duct?
Bleeding from the pancreatic duct often results from an arterial pseudoaneurysm associated with pancreatitis or a pancreatic fluid collection. Less common causes include trauma, pancreatic tumors, and complications of procedures.

A pseudoaneurysm is a contained leak from an artery, not simply a widened artery with all its usual wall layers intact. Pancreatic inflammation and enzymes can weaken a nearby vessel, allowing a fragile blood-filled cavity to form.
The splenic artery is a recognized source because it runs close to the pancreas, although other nearby arteries can be involved. The precise vessel matters because an interventional radiologist plans treatment around its anatomy.
A review by Tarar and colleagues describes pancreatitis, pseudoaneurysms, and pseudocysts among the clinical settings associated with this condition (Tarar et al., 2022). In a separate diagnostic context, an IgG4 result cannot by itself establish pancreatic disease or a bleeding source.
Why can bleeding stop and restart?
Hemosuccus pancreaticus can be intermittent because clots or temporary changes in flow may interrupt the passage of blood into the pancreatic duct. Symptoms can settle even though the underlying vessel remains at risk.

An examination performed between episodes may show no active blood at the papilla. That makes the timing of symptoms useful clinical information, not a reason to wait for another episode before seeking care.
For a hypothetical example, a person with prior pancreatitis has black stools on Monday and a normal-looking initial endoscopy on Tuesday. If symptoms recur, the team may reassess the pancreatic vessels rather than assume the first examination excluded every source.
A record of when stool changed, whether pain accompanied it, and any prior imaging can help clinicians compare events with investigations. Avoid self-testing during a suspected emergency; stool blood testing has a different purpose.
Why can an initial endoscopy miss the source?
An initial upper endoscopy can miss hemosuccus pancreaticus if bleeding is not active or the major papilla is difficult to inspect. A normal-looking stomach and duodenum therefore do not rule out a pancreatic duct source.

A standard upper endoscope examines the esophagus, stomach, and duodenum. It is valuable because ulcers and other more common upper gastrointestinal sources may be visible and treatable during the same procedure.
The papilla sits on the wall of the duodenum and may not be well seen with a forward-viewing scope. A side-viewing endoscope can provide a better view when specialists consider it appropriate, but it still may miss bleeding that has stopped.
Seeing blood emerge from the papilla can provide a strong clue, although clinicians must also consider blood coming from the bile duct. Other gastrointestinal diagnoses can likewise require a specific technique, as explained in our article on endoscopy and biopsy.
How does CT angiography help diagnosis?
CT angiography, or CTA, uses contrast and timed CT images to examine blood vessels and may show a pseudoaneurysm or active contrast leakage. It can also reveal pancreatitis, a fluid collection, or blood within the pancreatic duct.

A multiphase study captures images at different times after contrast injection. The phases help a radiologist distinguish vessel anatomy from contrast that has escaped into nearby tissue or a duct.
A negative CTA does not exclude intermittent hemorrhage, particularly when there is no active flow at the time of imaging. A visible pseudoaneurysm may still be clinically significant even when active leakage is not seen.
The team considers contrast allergy and kidney function when choosing imaging, but potentially life-saving investigation should not be delayed without a clinical reason. BUN と クレアチニン provide context about kidney function; neither test locates gastrointestinal bleeding.
What does catheter angiography add?
Catheter angiography maps arteries using contrast delivered through a small catheter and can identify a pancreatic arterial source. When an appropriate vessel is found, the same procedure can often treat it.

An interventional radiologist guides the catheter into selected arteries and takes images of the vessel network. The examination may reveal a pseudoaneurysm or active leakage, but intermittent bleeding can also make angiography negative.
A coil or another embolic material may be placed to block the responsible vessel. The choice depends on the artery, its branches, and the need to preserve circulation to nearby organs.
The team weighs procedure-related risks, including reduced blood supply to surrounding tissue, against the danger of continued bleeding. A crossmatch before transfusion may be needed as part of the broader emergency plan.
When are endoscopic ultrasound and ERCP used?
Endoscopic ultrasound and ERCP can provide additional information when the diagnosis remains uncertain, but neither replaces urgent stabilization or vascular imaging when a serious arterial bleed is suspected.

Endoscopic ultrasound places an ultrasound probe close to the pancreas from inside the digestive tract. Doppler imaging may help assess a nearby vessel or a pancreatic fluid collection, depending on the clinical question and local expertise.
ERCP, or endoscopic retrograde cholangiopancreatography, uses an endoscope and contrast to examine or treat selected pancreatic and bile duct problems. It is invasive and can cause pancreatitis or other complications, so specialists select it for a specific reason.
Finding a duct abnormality does not automatically prove it caused a bleed. Imaging findings and symptoms must be considered together, much as a pancreatic marker result requires clinical context.
Which blood tests help assess a suspected bleed?
A complete blood count, blood group and compatibility testing, kidney function tests, and clotting tests help clinicians assess and prepare for gastrointestinal bleeding. None can independently diagnose hemosuccus pancreaticus.

Hemoglobin measures the oxygen-carrying protein in red cells. After sudden blood loss, the first value may not yet show the eventual fall, so the team interprets repeat results alongside pulse, blood pressure, symptoms, and treatment.
In the American College of Gastroenterology guideline for hospitalized upper gastrointestinal bleeding, a hemoglobin threshold of 7 g/dL is suggested for transfusion in many patients (Laine et al., 2021). That is not a home-care cutoff: active bleeding, shock, heart disease, and other circumstances require individualized decisions.
カンテスティは AI血液検査分析装置 that can help explain reported hemoglobin and other CBC values after urgent care has been arranged. It cannot assess circulation, replace repeat testing, or find a pancreatic vessel; see our explanation of hemoglobin and hematocrit.
Can a stool test identify pancreatic duct bleeding?
No routine stool test can identify the pancreatic duct as the source of bleeding. A fecal occult blood test or FIT may detect blood in some circumstances, but it cannot show where that blood originated.

FIT detects human hemoglobin and is mainly used in specific screening or assessment pathways for lower gastrointestinal bleeding. Blood from an upper source may be digested before it reaches the stool, so a negative FIT cannot safely rule out an upper gastrointestinal bleed.
A positive screening test needs follow-up for its own reasons; it does not prove pancreatic bleeding or cancer. Visible black tarry stool or vomiting blood warrants urgent clinical assessment rather than a home screening kit.
Stool inflammation tests answer a different question again. Our comparison of カルプロテクチンとラクトフェリンの比較 explains why markers of intestinal inflammation do not localize an arterial bleed.
How is hemosuccus pancreaticus treated?
Treatment combines resuscitation with a plan to control the bleeding source, often using catheter embolization when the anatomy allows. Surgery may be necessary if embolization fails, is unsuitable, or another pancreatic problem also needs an operation.

In hospital, clinicians monitor vital signs, establish intravenous access, and give fluids or blood products when needed. They also review anticoagulants and other medicines that can affect bleeding, balancing reversal against each person's clotting risk.
Embolization can stop flow through the affected artery without open surgery. Repeat imaging or another intervention may be needed if bleeding returns, because the initial procedure does not guarantee permanent control.
正常な clotting panel does not rule out a damaged artery. Do not stop a prescribed anticoagulant independently unless the treating emergency team directs you to do so.
What follow-up is needed after treatment?
Follow-up after hemosuccus pancreaticus focuses on recurrent bleeding, recovery from anemia, and the pancreatic or vascular problem that caused the event. The schedule depends on the intervention and the person's condition.

Before leaving hospital, ask which symptoms should trigger emergency care and whom to contact about non-emergency questions. New vomiting of blood, black tarry stool, fainting, or marked weakness should not wait for a scheduled appointment.
Repeat hemoglobin and, when appropriate, iron studies can help track recovery. Low ferritin may suggest depleted iron stores, but inflammation can complicate its interpretation; our 鉄の研究ガイド explains the related markers.
カンテスティは AI血液検査の読み方プラットフォーム that can help organize follow-up laboratory results for discussion with a clinician. Its 責任あるAIに関する情報 explains why an automated interpretation is not a substitute for clinical decisions.
What should you ask your care team?
Ask your care team whether a source has been confirmed, whether a pancreatic vessel or fluid collection was seen, and what to do if bleeding returns. These questions clarify both the current diagnosis and the plan if uncertainty remains.

Useful questions include: “Was the papilla seen during endoscopy?”, “Did the scan show a pseudoaneurysm?”, and “Would repeat imaging or specialist review be appropriate if symptoms recur?” The answers depend on the actual examination and your clinical stability.
If treatment was performed, ask which vessel was treated, whether further imaging is planned, and when medicines can safely be resumed. Keep copies of the discharge summary and imaging reports available for future emergency visits.
Kantesti can support discussion of laboratory trends, but it cannot confirm a bleeding source or advise you to delay care. Our 医療コンテンツ基準 describe the approach used for health information on the site.
よくある質問
膵管出血は緊急事態ですか?
膵管出血は、罹患した動脈から大量出血したり、再出血したりする可能性があるため、生命を脅かす緊急事態となることがあります。出血が疑われる状況で、吐血、黒色タール便、失神、または重度の脱力感がある場合は、直ちに救急評価を受けてください。2回目の発作や便検査を待たずに、すぐに助けを求めてください。
内視鏡検査で膵管出血を見逃すことはありますか?
はい。出血が止まっている場合や膵管開口部がはっきり見えない場合、上部内視鏡検査では膵管内出血を見逃すことがあります。状況に応じて、医療従事者は側視鏡検査、CT血管造影、または他の専門的な検査を検討することがあります。検査で陰性だったからといって、間欠的な出血が必ず否定されるわけではありません。
膵管内出血が疑われる場合、最も有用な画像検査は何ですか?
CT血管造影は、膵仮性動脈瘤、活動性造影剤漏出、および関連する膵臓の変化を描出できるため、有用なことがよくあります。カテーテル血管造影では、より詳細な動脈画像が得られ、治療も行える場合があります。出血が間欠的な場合、いずれの検査も陰性となることがあるため、臨床医は症状やその他の所見とあわせて結果を解釈します。
Can a normal hemoglobin rule out pancreatic duct bleeding?
No. Hemoglobin can initially remain in the reference range after sudden blood loss and cannot identify where bleeding originated. Clinicians may repeat a complete blood count and assess blood pressure, pulse, symptoms, and imaging. An emergency transfusion decision is based on the whole clinical picture, not one laboratory number alone.
Does a positive FIT diagnose hemosuccus pancreaticus?
No. A positive FIT detects human hemoglobin in stool but does not locate the source or diagnose hemosuccus pancreaticus. A negative FIT also cannot reliably exclude an upper gastrointestinal bleed, because blood may be digested before it reaches the stool. Visible bleeding or black tarry stool requires clinical assessment rather than waiting for a screening test.
Can hemosuccus pancreaticus be treated without surgery?
Hemosuccus pancreaticus can sometimes be treated without open surgery through catheter-directed embolization of the responsible artery. The approach depends on the vessel anatomy, the person's stability, and available expertise. Surgery remains an option when embolization is not feasible, fails, or another pancreatic problem requires an operation.
血液検査結果の見方を確認しましょう
検査報告書をアップロードすると、KantestiのAIが数秒で各バイオマーカーを平易な言葉で説明します。世界中で200万人以上が利用しています。.
参考文献
- Klein, T., Mitchell, S., & Weber, H. (2026). BUN/クレアチニン比の説明:腎機能検査ガイド。. Kantesti AI医学研究。. 掲載日
- Klein, T., Mitchell, S., & Weber, H. (2026). 尿中ウロビリノーゲン検査:完全尿検査ガイド2026。. Kantesti AI医学研究。. 掲載日
- Tarar ZI et al. (2022). Hemosuccus Pancreaticus: A Comprehensive Review of Presentation, Diagnosis, and Management. Gastroenterology Research.
- Laine L et al. (2021). ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding. American Journal of Gastroenterology. 掲載日
- 200万以上分析対象の検査
- 127+国
- 100+言語
医療チームについて

トーマス・クライン医学博士
筆頭著者 · 医学監修者
カンテスティAI最高医療責任者
Thomas Klein医師は、検査医学およびAI支援臨床解析で15年以上の経験を持つ、専門医認定を受けた臨床血液専門医・内科医です。.

サラ・ミッチェル医学博士
医療アドバイザー
臨床病理学および内科主任医療顧問
サラ・ミッチェル博士は、認定臨床病理専門医であり、検査医学および診断分析において18年以上の経験を持ちます。臨床化学の専門資格を有し、臨床現場におけるバイオマーカーパネルおよび検査分析について、幅広く発表しています。.

ハンス・ウェーバー教授(博士)
寄稿専門家
臨床検査医学および臨床生化学の教授
ハンス・ウェーバー教授(Dr.)は、臨床生化学、検査医学、バイオマーカー研究において30年以上の専門知識を持ちます。ドイツ臨床化学会の元会長であり、診断パネル解析、バイオマーカーの標準化、AI支援による検査医学を専門としています。.
E-E-A-T 信頼性シグナル
経験
医師主導による、検査結果解釈ワークフローの臨床レビュー。.
専門知識
臨床的な文脈においてバイオマーカーがどのように振る舞うかに焦点を当てた検査医学。.
権威
Thomas Klein医師による医学的レビュー。Sarah Mitchell医師およびHans Weber教授の協力。.
信頼性
アラームを減らすための明確なフォローアップ経路を備えた、エビデンスに基づく解釈。.
続きを読む
さらに医療ガイド: カンテスティ 医療チーム:

JAK2変異検査の結果:陽性が意味すること
JAK2変異検査の陽性または陰性の結果、低いアレル負荷、エクソン12の所見について理解しましょう。何について相談すべきかを学びましょう…
記事を読む →
尿中ポルフォビリノーゲン検体の取り扱い:実践ガイド
光、尿の希釈、採取のタイミングがPBG検査に及ぼす影響と、症状に対して緊急の診療が必要となるタイミングについて学びます。実践的な…
記事を読む →
オクスカルバゼピン血中濃度:MHDの基準範囲、測定タイミング、安全な次のステップ
オクスカルバゼピンの血中濃度や、検査でMHDが測定される理由、採血のタイミングが結果に及ぼす影響を理解しましょう。より安全な薬物療法のために質問を準備しましょう…
記事を読む →
ポサコナゾール濃度:低値の結果、吸収および目標値
ポサコナゾール濃度が低い場合、服薬忘れではなく、吸収不良、製剤、または検査のタイミングが原因の可能性があります。トラフ値の目標範囲と、確認すべき点を…
記事を読む →
妊娠前のレフルノミド排泄促進:安全な検査方法
妊娠前のレフルノミドのウォッシュアウトを、明確な用量、血液検査の基準値、英国と米国のタイミングの違いとともに計画しましょう。確認すべきことを確認しましょう…
記事を読む →
PFAPA症候群:発熱パターン、症状、診断
PFAPA症候群は、口内炎、喉の痛み、首のリンパ節の腫れを伴う発熱を繰り返します。発熱のパターンや有用な検査などについて解説します…
記事を読む →私たちのすべての健康ガイドと AIによる血液検査分析ツールを at kantesti.net
医療免責事項
この記事は教育目的のみを対象としており、医療助言を構成するものではありません。診断や治療の判断を行う際は、必ず有資格の医療提供者にご相談ください。.
公開 · 編集チームにお問い合わせください
Kantesti Ltdが発行。イングランドおよびウェールズで登録、会社番号. 17090423, 、英国ロンドン。.